移植后的贫血和铁缺乏症:一个未解决的挑战
Jose Portolés1, Rainer Oberbauer2, Michele F Eisenga3
1Dept of Nephrology & Transplantation, University Hospital Puerta de Hierro IDIPHISA, Madrid, Spain Anaemia Working Group of the Spanish Society of Nephrology (S.E.N.), Transplant Working Group of S.E.N. (SENTRA), Madrid, Spain.
Clinical kidney journal
|September 10, 2025
概括
贫血和铁缺乏症在移植接受者中很常见,影响生活质量和结果. 目前的指导方针忽略了移植的特定因素,需要为这些患者量身定制的意识和研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
- 血液学 血液学 血液学
背景情况:
- 贫血和缺铁 (ID) 是移植接受者 (KTRs) 的普遍并发症.
- 现有的贫血指南不充分地解决了与非移植慢性病 (CKD) 患者相比,KTR患者的移植后贫血 (PTA) 独特的病理生理学和临床方面.
- 在KTR患者中,PTA和ID的临床关注往往比在非移植CKD人群中少.
研究的目的:
- 审查KTRs中关于PTA和ID的具体证据.
- 突出PTA和ID与患者存活率,移植存活率和与健康相关的生活质量 (HRQoL) 的关联.
- 讨论当前的管理策略,并确定KTR中PTA和ID的知识和治疗指南中的差距.
主要方法:
- 这项研究是对移植患者贫血和缺铁现有文献的叙事性综述.
- 该审查综合了有关流行,特定病理生理因素,管理选择和临床结果的证据.
- 它批判性地评估了与KTRs相关的当前指导方针和治疗方法.
主要成果:
- 贫血在KTR患者中比在非移植CKD患者中更为频繁,由于移植特异性因素,他们具有相似的膜过率 (GFR).
- 缺铁需要用口服或静脉注射铁检测和纠正,并注意某些静脉注射配方的潜在并发症,如低酸血症.
- 目前的红血球标对红色受体刺激剂可能不是最佳的,因为更高的标与KTRs中更慢的GFR下降有关.
结论:
- 在KTR中,PTA和ID是不同的临床问题,需要超出一般CKD指南的专业关注.
- 管理应专注于铁补充和个性化血红蛋白标,同时避免输血红细胞.
- 提高认识和有针对性的临床试验对于优化贫血和ID的KTR护理至关重要.
相关概念视频
01:28Kidney Transplant I: Introduction
349
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
349
01:16Kidney Transplant III: Nursing Management
321
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
321
01:26Kidney Transplant II: Surgical Procedure
325
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
325
01:24Chronic Kidney Disease II: Clinical Manifestations
559
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
559
01:28Chronic Kidney Disease III: Interprofessional Care
346
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
01:22Bone Marrow Sampling and Transplants
910
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910